Gene Polymorphisms Associated with Central Precocious Puberty and Hormone Levels in Chinese Girls

Yunwei Li, Tao Na, Ming‐Hui Chen, Jiang Chu, Xinwei Huang, Xiangyang KongInternational Journal of Endocrinology 2022 · DOI

TL;DR

This study investigates the genetic underpinnings of central precocious puberty (CPP) in Chinese girls by examining single nucleotide polymorphisms (SNPs) in key genes. They found specific genetic variations in KISS1, SIRT1, and VDR genes associated with increased or decreased CPP risk, and importantly, demonstrated that VDR gene variants influence hormone levels related to puberty onset.

What Problem Does This Paper Address?

Central precocious puberty (CPP) is a condition where puberty begins unusually early, leading to potential adverse health outcomes like obesity and increased risk of certain cancers. While its exact causes are complex and multifactorial, genetic predisposition is known to play a significant role, accounting for a substantial portion of pubertal timing variation. However, the specific genetic variants contributing to CPP, especially in diverse populations like Chinese girls, remain largely unclear. This paper aims to fill this knowledge gap by identifying gene polymorphisms associated with CPP risk and their impact on crucial hormone levels that regulate pubertal development.

Methods

The researchers employed a case-control study design, recruiting 247 girls diagnosed with CPP and 243 healthy control girls. They focused on 20 single nucleotide polymorphisms (SNPs) located in eight genes (KISS1, LIN28B, ERA, ERB, TMEM38B, SIRT1, VDR, and PLCB1) that have been previously linked to precocious puberty, its clinical features, or metabolic disorders. DNA was extracted from blood samples, and SNP genotyping was performed using a Snapshot genotyping method. Statistical analyses included Hardy-Weinberg equilibrium testing, logistic regression for CPP risk assessment (using an additive model), and linear regression to evaluate the association between SNPs and hormone levels (peak LH, peak FSH, basal FSH, basal LH, estradiol (E2), and insulin-like growth factor (IGF-1)), adjusting for age and BMI. Haplotype analysis was also conducted to examine combinations of SNPs.

Datasets

The study utilized a dataset of 247 girls with central precocious puberty (CPP) and 243 healthy control girls recruited from Kunming Children's Hospital, China, between September 2019 and August 2020. No new datasets or benchmarks were introduced; the study relied on existing clinical data and genetic information from these participants.

Key Insights and Ideas

  • KISS1, SIRT1, and VDR are key players: The study strongly implicates variations in KISS1, SIRT1, and VDR genes in the susceptibility to CPP. This highlights the central role of these genes in the hypothalamic-pituitary-gonadal (HPG) axis regulation.
  • SIRT1's dual role: Interestingly, while some SIRT1 variants were associated with increased CPP risk, one variant (rs3740051) showed a protective effect, suggesting a complex regulatory role for SIRT1 in pubertal timing.
  • VDR's hormonal influence: The most significant finding is the demonstration that VDR gene polymorphisms directly influence hormone levels critical for puberty. Specifically, rs1544410 in VDR was linked to both CPP risk and GnRH-stimulated peak FSH levels, suggesting a potential mechanism for its protective effect.
  • Haplotypes matter: Beyond individual SNPs, certain combinations of SNPs (haplotypes) within KISS1 and SIRT1 also showed significant associations with CPP risk, underscoring the importance of considering genetic interactions.

Key Results

  • Increased CPP risk: Five SNPs were associated with an increased risk of CPP: three in KISS1 (rs10159082, rs7538038, rs5780218) and two in SIRT1 (rs7895833, rs3758391). Odds ratios ranged from 1.348 to 1.737.
  • Decreased CPP risk: Two SNPs showed a protective effect against CPP: rs3740051 in SIRT1 (OR = 0.689) and rs1544410 in VDR (OR = 0.464).
  • Hormonal correlations: VDR gene variants were significantly correlated with hormone levels in CPP cases. Specifically, rs1544410, rs7975232, and rs731236 in VDR were negatively correlated with peak FSH, basal FSH, and IGF-1 levels.
  • VDR rs1544410's dual impact: The VDR polymorphism rs1544410 was uniquely associated with both a reduced risk of CPP and lower GnRH-stimulated peak FSH levels.

Limitations and Future Work

The authors acknowledge several limitations:

  • Lack of control group hormone data: Hormone levels were only measured in CPP cases, limiting the ability to fully understand how SNP associations with hormones in CPP cases translate to overall CPP risk.
  • Limited number of loci: The study investigated a selected set of SNPs, and a broader investigation of more genetic loci and variants is needed to fully elucidate the complex genetic architecture of CPP.

Future work should focus on:

  • Functional studies: Investigating the precise molecular mechanisms by which these identified gene variants influence gene expression and protein function.
  • Large-scale genetic studies: Validating these findings in larger, diverse populations to confirm the associations and identify additional genetic factors.
  • Measuring hormone levels in controls: Including hormone measurements in the control group would strengthen the analysis of SNP-hormone associations.

Summary updated

Abstract

Central precocious puberty (CPP) is associated with adverse health outcomes in females; however, CPP pathogenesis remains unclear. In this study, we investigated the association of 20 single nucleotide polymorphisms (SNPs) in eight genes with CPP risk and hormone levels. A case-control study on 247 and 243 girls with and without CPP, respectively, was conducted at Kunming Children's Hospital, China, from September 2019 to August 2020. The genotype of the SNPs and their haplotypes were identified. Additionally, the effects of the polymorphisms on hormone levels were investigated. Three variants (rs10159082, rs7538038, and rs5780218) in <i>KISS1</i> and two variants (rs7895833 and rs3758391) in <i>SIRT1</i> were related to an increased CPP risk (odds ratio (OR) = 1.524, 1.507, 1.409, 1.348, and 1.737; 95% confidence interval (CI) = 1.176-1.974, 1.152-1.970, 1.089-1.824, 1.023-1.777, and 1.242-2.430, respectively). Rs3740051in <i>SIRT1</i> and rs1544410 in <i>VDR</i> reduced CPP risk (OR = 0.689, 0.464; 95% CI, 0.511-0.928, 0.232-0.925, respectively). Rs1544410, rs7975232, and rs731236 in <i>VDR</i> were negatively correlated with peak follicle-stimulating hormone (FSH; <i>β</i> = -2.181; <i>P</i>=0.045), basal FSH (<i>β</i> = -0.391; <i>P</i>=0.010), and insulin-like growth factor (<i>β</i> = -50.360; <i>P</i>=0.041) levels, respectively. <i>KISS1</i>, <i>SIRT1</i>, and <i>VDR</i> variants were associated with CPP susceptibility, and <i>VDR</i> SNPs influenced hormonal levels in Chinese females with CPP. In particular, <i>VDR</i> polymorphism rs1544410 was associated with both CPP risk and GnRH-stimulated peak FSH levels. Further functional research and large-scale genetic studies of these loci and genes are required to confirm our findings.
BibTeX
@article{li2022gene,
  author = {Yunwei Li and Tao Na and Ming‐Hui Chen and Jiang Chu and Xinwei Huang and Xiangyang Kong},
  title = {{Gene Polymorphisms Associated with Central Precocious Puberty and Hormone Levels in Chinese Girls}},
  journal = {International Journal of Endocrinology},
  year = {2022},
  doi = {10.1155/2022/9450663},
}
Figure